Tavaborole
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Tavaborole
- Generic name
- TAVABOROLE
- Manufacturer
- Zydus Lifesciences Limited
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 15bc62dc-4f5e-4d43-a125-d1f00bee84a5
- SPL ID
- b7ea9baf-cd2b-4430-a0cf-85945ce38a17
- Version
- 2
- Effective date
- 2024-12-06
- Source export date
- 2026-10-12
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:52:45
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 212294 | derived:openfda.application_number |
| application number | ANDA212294 | openfda.application_number | |
| brand name | Tavaborole | openfda.brand_name | |
| generic name | TAVABOROLE | openfda.generic_name | |
| manufacturer name | Zydus Lifesciences Limited | openfda.manufacturer_name | |
| ndc | package | 70771-1826-0 | openfda.package_ndc |
| ndc | product | 70771-1826 | openfda.product_ndc |
| ndc11 | package | 70771182600 | derived:openfda.package_ndc |
| rxcui | 1543177 | openfda.rxcui | |
| spl id | b7ea9baf-cd2b-4430-a0cf-85945ce38a17 | id | |
| spl set id | 15bc62dc-4f5e-4d43-a125-d1f00bee84a5 | set_id | |
| unii | K124A4EUQ3 | openfda.unii |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.